Early effects of levosimendan on LV function in patients with CCS and single vessel CTO of the LAD artery

9 May 2026 (08:00 - 12:45)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Marufjon Norkulov

Republican Specialized Cardiology Centre - Karshi Branch, Karshi (Uzbekistan)

5 More presentations in this session

Presentation thumbnail

Cardiogenetic Registry: Design and first Results on the prevalence of pathogenic variants in cardiomyopathies

Doctor N. Panagiotides (Vienna, AT)

Abstract Slides

Presentation thumbnail

Hypertensive response to exercise indexed to oxygen consumption: associations with cardio-vascular-renal function and prognosis across the spectrum of heart failure with preserved ejection fraction

Doctor N. De Biase (Pisa, IT)

Abstract Slides

Presentation thumbnail

Impact of non-invasive positive pressure ventilation on pulmonary artery diastolic pressure: a longitudinal physiologic analysis

Doctor R. Germany (Minnetonka, US)

Abstract Slides

Presentation thumbnail

Pilot study on hemodynamic monitoring in patients with advanced heart failure - comparison of non-invasive versus invasive hemodynamic monitoring

Doctor S. Macura (Berlin, DE)

Abstract Slides

Presentation thumbnail

Correlation of NT-proBNP, C-reactive protein, and renal function with left ventricular ejection fraction in HFpEF and HFmrEF

Doctor D. Milosevic (Nis, RS)

Abstract Slides

Access the full session

Session thumbnail

ePosters in chronic heart failure - pathophysiology and mechanisms (4)

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026

You may be interested in

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

Webinar

Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction

Congress Presentation

Audience Q&A

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources